Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer.

Loosen SH, Luedde M, Lurje G, Spehlmann M, Paffenholz P, Ulmer TF, Tacke F, Vucur M, Trautwein C, Neumann UP, Luedde T, Roderburg C.

Dis Markers. 2019 Oct 20;2019:5603474. doi: 10.1155/2019/5603474. eCollection 2019.

2.

Serum Levels of miR-143 Predict Survival in Critically Ill Patients.

Roderburg C, Koch A, Benz F, Vucur M, Spehlmann M, Loosen SH, Luedde M, Rehse S, Lurje G, Trautwein C, Tacke F, Luedde T.

Dis Markers. 2019 Oct 23;2019:4850472. doi: 10.1155/2019/4850472. eCollection 2019.

3.

A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients.

Roderburg C, Benz F, Koch A, Loosen SH, Spehlmann M, Luedde M, Wree A, Vucur M, Trautwein C, Tacke F, Luedde T.

J Clin Med. 2019 Oct 9;8(10). pii: E1644. doi: 10.3390/jcm8101644.

4.

Life is fragile: FMRP controls cell death in liver disease.

Vucur M, Luedde T.

Gut. 2020 Jan;69(1):2-3. doi: 10.1136/gutjnl-2019-319534. Epub 2019 Sep 25. No abstract available.

PMID:
31554707
5.

An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration.

Koppe C, Reisinger F, Wehr K, Vucur M, Trautwein C, Tacke F, Heikenwalder M, Luedde T.

Cancers (Basel). 2019 Jul 17;11(7). pii: E999. doi: 10.3390/cancers11070999.

6.

miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years.

Tacke F, Spehlmann ME, Vucur M, Benz F, Luedde M, Cardenas DV, Roy S, Loosen S, Hippe HJ, Frey N, Trautwein C, Koch A, Roderburg C, Luedde T.

Mediators Inflamm. 2019 Feb 24;2019:6714080. doi: 10.1155/2019/6714080. eCollection 2019.

7.

Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma.

Asimakopoulou A, Vucur M, Luedde T, Schneiders S, Kalampoka S, Weiss TS, Weiskirchen R.

Cancers (Basel). 2019 Mar 19;11(3). pii: E385. doi: 10.3390/cancers11030385.

8.

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.

Loosen SH, Lurje G, Wiltberger G, Vucur M, Koch A, Kather JN, Paffenholz P, Tacke F, Ulmer FT, Trautwein C, Luedde T, Neumann UP, Roderburg C.

PLoS One. 2019 Jan 17;14(1):e0210944. doi: 10.1371/journal.pone.0210944. eCollection 2019.

9.

Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer.

Seehawer M, Heinzmann F, D'Artista L, Harbig J, Roux PF, Hoenicke L, Dang H, Klotz S, Robinson L, Doré G, Rozenblum N, Kang TW, Chawla R, Buch T, Vucur M, Roth M, Zuber J, Luedde T, Sipos B, Longerich T, Heikenwälder M, Wang XW, Bischof O, Zender L.

Nature. 2018 Dec;564(7735):E9. doi: 10.1038/s41586-018-0723-9.

PMID:
30410124
10.

Serum levels of kisspeptin are elevated in critically ill patients.

Luedde M, Spehlmann ME, Hippe HJ, Loosen SH, Roy S, Vargas Cardenas D, Vucur M, Frey N, Koch A, Luedde T, Trautwein C, Tacke F, Roderburg C.

PLoS One. 2018 Oct 17;13(10):e0206064. doi: 10.1371/journal.pone.0206064. eCollection 2018.

11.

Necroptosis microenvironment directs lineage commitment in liver cancer.

Seehawer M, Heinzmann F, D'Artista L, Harbig J, Roux PF, Hoenicke L, Dang H, Klotz S, Robinson L, Doré G, Rozenblum N, Kang TW, Chawla R, Buch T, Vucur M, Roth M, Zuber J, Luedde T, Sipos B, Longerich T, Heikenwälder M, Wang XW, Bischof O, Zender L.

Nature. 2018 Oct;562(7725):69-75. doi: 10.1038/s41586-018-0519-y. Epub 2018 Sep 12. Erratum in: Nature. 2018 Nov 8;:.

PMID:
30209397
12.

microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.

Roy S, Hooiveld GJ, Seehawer M, Caruso S, Heinzmann F, Schneider AT, Frank AK, Cardenas DV, Sonntag R, Luedde M, Trautwein C, Stein I, Pikarsky E, Loosen S, Tacke F, Ringelhan M, Avsaroglu SK, Goga A, Buendia MA, Vucur M, Heikenwalder M, Zucman-Rossi J, Zender L, Roderburg C, Luedde T.

Gastroenterology. 2018 Dec;155(6):1951-1966.e26. doi: 10.1053/j.gastro.2018.08.032. Epub 2018 Aug 27.

13.

Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer.

Pombeiro I, Loosen SH, Roy S, Schueller F, Niewenhuisen L, Luedde M, Vucur M, Tacke F, Binnebösel M, Schoening W, Trautwein C, Luedde T, Neumann UP, Roderburg C.

J Clin Med. 2018 Jul 13;7(7). pii: E175. doi: 10.3390/jcm7070175.

14.

Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients.

Luedde M, Roy S, Hippe HJ, Cardenas DV, Spehlmann M, Vucur M, Hoening P, Loosen S, Frey N, Trautwein C, Luedde T, Koch A, Tacke F, Roderburg C.

Sci Rep. 2018 Jun 27;8(1):9750. doi: 10.1038/s41598-018-28201-7.

15.

Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases.

Loosen SH, Tacke F, Binnebosel M, Leyh C, Vucur M, Heitkamp F, Schoening W, Ulmer TF, Alizai PH, Trautwein C, Koch A, Longerich T, Roderburg C, Neumann UP, Luedde T.

Oncotarget. 2018 Jun 5;9(43):27027-27038. doi: 10.18632/oncotarget.25471. eCollection 2018 Jun 5.

16.

IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies.

Loosen SH, Schulze-Hagen M, Leyh C, Benz F, Vucur M, Kuhl C, Trautwein C, Tacke F, Bruners P, Roderburg C, Luedde T.

Int J Mol Sci. 2018 Jun 14;19(6). pii: E1766. doi: 10.3390/ijms19061766.

17.

Circulating Biomarkers for Cholangiocarcinoma.

Loosen SH, Vucur M, Trautwein C, Roderburg C, Luedde T.

Dig Dis. 2018;36(4):281-288. doi: 10.1159/000488342. Epub 2018 May 15. Review.

PMID:
29807369
18.

Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment.

Vucur M, Roderburg C, Kaiser L, Schneider AT, Roy S, Loosen SH, Luedde M, Trautwein C, Koch A, Tacke F, Luedde T.

Dis Markers. 2018 Feb 11;2018:1983421. doi: 10.1155/2018/1983421. eCollection 2018.

19.

The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.

Schueller F, Roy S, Vucur M, Trautwein C, Luedde T, Roderburg C.

Int J Mol Sci. 2018 Jan 16;19(1). pii: E261. doi: 10.3390/ijms19010261. Review.

20.

CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.

Loosen SH, Roderburg C, Kauertz KL, Koch A, Vucur M, Schneider AT, Binnebösel M, Ulmer TF, Lurje G, Schoening W, Tacke F, Trautwein C, Longerich T, Dejong CH, Neumann UP, Luedde T.

Sci Rep. 2017 Dec 5;7(1):16975. doi: 10.1038/s41598-017-17175-7.

Supplemental Content

Loading ...
Support Center